NCT06522087

Brief Summary

Delirium is an acute confusional state, it is a sign of acute encephalopathy, also known as acute brain failure, acute brain dysfunction or mental state changes.Postoperative delirium can cause post-traumatic stress disorder, affects patients' quality of life, extend the length of hospital stay, increased hospitalization cost, and is closely relative to short-term and long-term mortality after surgery. Exogenous 40 Hz stimulation can improve cognitive functioning. Therefore, the aim of this study was to investigate the effect of exogenous 40Hz stimulation on the incidence of postoperative delirium in elderly patients undergoing hip and knee replacement.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 22, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 26, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2025

Completed
Last Updated

August 28, 2024

Status Verified

July 1, 2024

Enrollment Period

11 months

First QC Date

July 22, 2024

Last Update Submit

August 26, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • The incidence of postoperative delirium

    Postoperative delirium was assessed by CAM scale.The diagnosis of delirium mainly depends on four characteristics: 1 acute fluctuating course; 2 attention disorder; 3 thinking disorder; 4 change of consciousness level. At the same time, 1 and 2, and 3 or 4 can be used to diagnose delirium.

    Day 1, Day 2, Day 3 after surgery

Secondary Outcomes (4)

  • Blood Markers

    Preoperative and postoperative 1 d and 2 d

  • The incidence of postoperative nausea and vomiting

    Day 1, Day 2, Day 3 after surgery

  • Sleep quality

    Day 1, day 2, day 3 after surgery

  • The incidence of pain

    Day 1, day 2, day 3 after surgery

Study Arms (2)

40Hz stimulation group

EXPERIMENTAL

At the start of anesthesia, the subject received 40Hz transcranial stimulation for 1h.

Device: 40Hz stimulation

Control group

NO INTERVENTION

At the start of anesthesia, the subject did not receive any additional treatment.

Interventions

Exogenous 40HZ stimulation is a physical intervention that can drive oscillations in the gamma range, and the oscillations and pulses caused at the corresponding frequency can lead to a significant reduction in β-amyloid, reverse tau hyperphosphorylation, and thereby improve the cognitive function of patients.

40Hz stimulation group

Eligibility Criteria

Age65 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • years old, gender not limited 2.General anesthesia unilateral total hip replacement surgery or unilateral total knee replacement 3.ASA classification I-III 4.No drugs for mental and central nervous system diseases were used before surgery 5.Preoperative MMSE score illiterate \> 17 points, primary \> 20 points, junior high school and above \> 24 points 6.Obtaining informed consent

You may not qualify if:

  • Severe liver and kidney dysfunction
  • here were mental and nervous system diseases before operation
  • Have a history of alcoholism, long-term use of sedative or analgesic
  • A history of a delirium and other reasons are reluctant to cooperate
  • Massive blood loss and blood transfusion during operation, prolonged operation time

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Henan People's Hospital

Zhengzhou, Henan, China

RECRUITING

MeSH Terms

Conditions

Emergence Delirium

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental Disorders

Central Study Contacts

Zhang jiaqiang

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 22, 2024

First Posted

July 26, 2024

Study Start

May 1, 2024

Primary Completion

March 15, 2025

Study Completion

March 15, 2025

Last Updated

August 28, 2024

Record last verified: 2024-07

Locations